The decline of androgen levels in elderly men and its clinical and therapeutic implications
about
Paternal age and reproductionDevelopmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4The benefits and risks of testosterone replacement therapy: a reviewLessons from the Bone Chapter of the Malaysian Aging Men StudyAn update on the role of testosterone replacement therapy in the management of hypogonadismTestosterone deficiency in the aging maleAndrogen receptor (AR) in cardiovascular diseasesA Positive Affective Neuroendocrinology Approach to Reward and Behavioral DysregulationA concise review of testosterone and bone healthRole of RUNX2 in Breast CarcinogenesisPatient satisfaction with testosterone replacement therapies: the reasons behind the choicesEndocrine disruptors and prostate cancer riskActions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer riskA validated age-related normative model for male total testosterone shows increasing variance but no decline after age 40 yearsCell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasiaEstrogens in Male PhysiologySex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study.Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Inverse associations between androgens and renal function: the Young Men Cardiovascular Association (YMCA) study.A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesisConfounding factors and genetic polymorphism in the evaluation of individual steroid profilingA critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.Sex-specific metabolic profiles of androgens and its main binding protein SHBG in a middle aged population without diabetesCould androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?The effects of opioids and opioid analogs on animal and human endocrine systemsIs there a paternal age effect for aneuploidy?Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.Clinical significance of androgen secretion disorders in men with a malignancy.New therapy via targeting androgen receptor in monocytes/macrophages to battle atherosclerosis.Genetic determinants of serum testosterone concentrations in men.Serum testosterone levels and mortality in men with CKD stages 3-4Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Testosterone deficiency accelerates neuronal and vascular aging of SAMP8 mice: protective role of eNOS and SIRT1LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity.Testosterone exacerbates neuronal damage following cardiac arrest and cardiopulmonary resuscitation in mouse.A practical guide to male hypogonadism in the primary care setting.
P2860
Q22337137-0E8866AA-57F0-4172-AA5A-2071A314BAABQ24648201-223568BF-9D23-491F-ABAA-232F8672173CQ24658011-44E04EE4-AC42-4DD2-B3DA-FBF90BD720D5Q26745567-FA846AE8-D8BD-41B2-A3F8-26DC513F030BQ26749076-D8718EC2-543D-4B8B-A254-12E797DCB2F3Q26770414-5EFB647A-C27C-4090-BFC9-D2E0C58CD31BQ26771962-6EB8F6DE-E344-4607-A8BB-F820D67A038DQ26802127-B438B7ED-4C33-451A-BABC-10A51C9F5142Q28066891-392A402C-2656-48EB-BB19-D17D087497BEQ28084968-237CF7A0-B5F8-4B9E-BF32-3585AF44273BQ28304192-B4234E78-E6C6-463B-B1C2-DA2FB4DD88F0Q28393584-D851A5D6-9744-4A58-AAB3-2CA4F01D8C15Q28395212-F61E1937-0B34-47BD-A273-5BAA0C73DADCQ28543619-394CABDC-A52B-4CD7-B96D-106E403ED06DQ28572109-93548E63-2BC3-4CBC-9844-B83C3604318DQ30090708-ED7FBD57-8E0D-4C32-88C0-FACC1EB6BEA6Q30490829-34890DE1-42A6-4E35-B5E8-A95A77DF64B6Q30587292-87A365B1-3D80-4FF1-8818-5CCA72B91BDDQ31112152-38805B33-12EC-44AE-9369-8DD375BCE06FQ33569163-59A5495F-8F1A-4995-A049-DE3362CA860AQ33597287-C11BA1B7-1641-430B-8C62-5DA8DB642D66Q33637973-E2AFB605-FA92-4BE3-93D1-3690CD6CA742Q33642456-AE69688E-FAFD-40E0-B32C-C8DB44D7F331Q33659461-38C81C91-1ED8-40A0-AF3F-A1FF52A38078Q33690473-9442E52F-8A9E-44DE-9489-C5421E20AF14Q33714851-C20CE6C1-2BC6-447A-8563-FB46A2D6BEF9Q33722061-DF2858E2-76E3-49E6-8BDC-974F7B42C10AQ33779667-53B986A2-E5A8-4172-B320-15216CBB7754Q33787921-3AE80AE3-0D66-4D7D-BDB0-0171CC161FC4Q33816511-67D6F917-D5F8-4CDA-972D-3E283CFCC311Q33840617-6E3051F0-C824-4307-A162-C92B51A41688Q33842431-0CD2CFD6-818E-4B65-8720-E8641584AA1BQ34048108-242C1790-F569-4B2F-821C-223EC2E5A097Q34084357-AE6EB19B-2938-4E1B-BA9D-C19319E368ABQ34091893-C80868F5-8A28-4FC8-A5C2-7B58DC6B39E3Q34097510-CBFDE15B-E7CD-4E6E-96AB-20485DFB2C17Q34125136-25B0E0FA-31F3-4605-B3CA-87E91691AA14Q34155724-59A2FCC9-0E66-41F3-9D9F-41C8570514C4Q34159170-D9F4FEBE-DAEF-4C60-9B62-404F31AAD626Q34167760-13DBF80D-94F6-4D18-81E5-B84AA09D4735
P2860
The decline of androgen levels in elderly men and its clinical and therapeutic implications
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The decline of androgen levels ...... l and therapeutic implications
@ast
The decline of androgen levels ...... l and therapeutic implications
@en
The decline of androgen levels ...... l and therapeutic implications
@nl
type
label
The decline of androgen levels ...... l and therapeutic implications
@ast
The decline of androgen levels ...... l and therapeutic implications
@en
The decline of androgen levels ...... l and therapeutic implications
@nl
prefLabel
The decline of androgen levels ...... l and therapeutic implications
@ast
The decline of androgen levels ...... l and therapeutic implications
@en
The decline of androgen levels ...... l and therapeutic implications
@nl
P3181
P356
P1433
P1476
The decline of androgen levels ...... l and therapeutic implications
@en
P2093
Alex Vermeulen
Jean M Kaufman
P304
P3181
P356
10.1210/ER.2004-0013
P407
P577
2005-10-01T00:00:00Z